Differential fddnp pet patterns in nondemented middle-aged and older adults

American Journal of Geriatric Psychiatry

Volumn 17, Issue 5, 2009, Pages 397-406

  Ercoli, Linda M ^a   Siddarth, Prabha ^a   Kepe, Vladimir ^b   Miller, Karen J ^a   Huang, S C ^b   Cole, Gregory M ^b,c   Lavretsky, Helen ^a   Bookheimer, Susan Y ^a,c   Kim, Jeanne ^a   Phelps, Michael E ^b   Barrio, Jorge R ^b   Small, Gary W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid neuritic plaques; Mild cognitive impairment; Neurofibrillary tangles; Positron emission tomography

Indexed keywords

2 [1 [6-(2 FLUOROETHYLMETHYLAMINO) 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE F 18; FLUORINE 18; UNCLASSIFIED DRUG; 2 (1 (6 ((2 FLUOROETHYL)(METHYL)AMINO) 2 NAPHTHYL)ETHYLIDENE)MALONONITRILE; 2-(1-(6-((2-FLUOROETHYL)(METHYL)AMINO)-2-NAPHTHYL)ETHYLIDENE)MALONONITRILE; NITRILE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISTRIBUTION VOLUME; FEMALE; FRONTAL CORTEX; GROUPS BY AGE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; PARAMETRIC TEST; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; SENILE PLAQUE; TASK PERFORMANCE; TEMPORAL CORTEX; CLUSTER ANALYSIS; COGNITIVE DEFECT; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; RISK; SCINTISCANNING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBELLUM; CLUSTER ANALYSIS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROPSYCHOLOGICAL TESTS; NITRILES; POSITRON-EMISSION TOMOGRAPHY; RISK; SENILE PLAQUES;

EID: 66549122755     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318198750b     Document Type: Article

References (37)

1. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308
2. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Int Med 2004; 256:183-194
3. Loewenstein DA, Acevedo A, Ownby R, et al: Using different memory cutoffs to assess mild cognitive impairment. Am J Geriatr Psychiatry 2006; 14:911-919
4. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-259
5. Price JL, Morris JC: Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 1999; 45:358-368
6. Petersen RC, Parisi JE, DicksonDW, et al: Neuropathology of amnestic mild cognitive impairment. Arch Neurol 2006; 63:665-672
7. Bennett DA, Schneider JA, Bienias JL, et al: Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005; 64:834-841
8. Jicha GA, Parisi JE, Dickson DW, et al: Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 2006; 63:674-681
9. Lenze EJ, Mulsant BH. Biomarkers in geriatric psychiatry. Am J Geriatr Psychiatry 2007; 15:827-831
10. Klunk WE, Engler H, Nordberg A, et al: Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004; 55:306-319
11. Shoghi-Jadid K, Small GW, Agdeppa ED, et al: Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer's disease. Am J Geriatr Psychiatry 2002; 10:24-35
12. Agdeppa ED, Kepe V, Liu J, et al: Binding characteristics of radiofluorinated 6-dialkylamino-2-napthylethylidene derivatives as PET imaging probes â-amyloid plaques in Alzheimer's disease. J Neurosci 2001;21:RC189:1-5
13. Small GW, Kepe V, Ercoli LM, et al: PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006; 355:2652-2663
14. Agdeppa ED, Kepe V, Petric A, et al: In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2-[18F]fluoroethyl) (methyl)amino]-2-naphthyl}ethylidene) malononitrile. Neuroscience 2003; 117:723-730
15. Folstein M, Folstein S, McHugh P: "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
16. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
17. Lezak M, Howieson D, Loring D. Neuropsychological assessment, 4th ed. New York, University Press, 2004
18. Bilder RM, Goldman RS, Robinson D, et al: Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000; 7:549-59
19. Winblad B, Palmer K, Kivipelto M, et al: Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256:240-246
20. Busse A, Bischkopf J, Riedel-Heller SG, et al: Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med 2003; 33:1029-1038
21. Gilewski MJ, Zelinski EM. Questionnaire assessment of memory complaints, in Handbook for Clinical Memory Assessment of Older Adults. Edited by Poon LW. Washington, DC, American Psychological Association, 1986, pp 93-107
22. Kepe V, Barrio JR, Huang S-C, et al: Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci USA 2006; 103:702-707
23. Liu J, Kepe V, Zabjec A, et al: High yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]Fluoro-ethyl)(methyl)amino]-2-naphthyl} ethylidene) malononitrile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol 2007; 9:6-16
24. Logan J, Fowler J, Volkow N, et al: Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16:834-840
25. Talairach J, Tournoux P. Coplanar Stereotaxic Atlas of the Human Brain. Three-Dimensional Proportional System: An Approach to Cerebral Imaging. New York: Thieme, 1988
26. Lopresti BJ, Klunk WE, Mathis CA, et al: Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 2005; 46: 1959-1972
27. Guillozet AL, Weintraub S, Mash DC, et al: Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003; 60:729-736
28. Rowe CC, Ng S, Ackermann U, et al: Imaging beta-amyloid burden in aging and dementia. Neurology 2007; 68:1718-1725
29. Mosconi L, De Santi S, Li Y, et al: Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur J Nucl Med Mol Imaging 2006; 33:210-221
30. Bell-McGinty S, Lopez OL, Meltzer CC, et al: Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005; 62:1393-1397
31. Seo SW, Im K, Lee JM, et al: Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007; 36:289-297
32. Bozoki A, Giordani B, Heidebrink JL, et al: Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001; 58:411-416
33. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH: Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging 1996; 17:365-371
34. Knopman DS, Parisi JE, Salviati A, et al: Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003; 62:1087-1095
35. Schmitt FA, Davis DG, Wekstein DR, et al: "Preclinical" AD revisited: neuropathology of cognitively normal older adults Neurology 2000; 55:370-376
36. Tabert MH, Manly JJ, Liu X, et al: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63:916-924
37. Small GW, Kepe V, Huang SC, et al: In Vivo Brain Imaging of Tau Aggregation in Frontal Temporal Dementia Using [F-18]FDDNP Positron Emission Tomography. (Abstract) 9th International Conference on Alzheimer's Disease and Related Disorders, held in Philadelphia, PA, July 17-22, 2004